Finance
The deal comes less than a month after the company's plan to combine with digital neurotherapy company MindMaze fell through.
The raise brings the healthcare-focused firm's total committed capital to more than $1 billion.
The company's portable, battery-operated and Bluetooth-connected device with RPM capabilities enables patients to complete respiratory treatments from anywhere.
The company's revenue increased in Q2 of this year to $13.1 million compared to $10.7 million in the first quarter – still below the $18.3 million reported in Q2 2022.
The company also announced its intentions to seek FDA approval for EndeavorOTC, its over-the-counter product for adults with ADHD.
Medicare Advantage insurtech company Clover Health and virtual care company Hims & Hers Health also reported earnings.
The Tennessee-based company has regained compliance with the bid price requirement to remain listed on the NASDAQ.
The company also seeks to sell its U.K. business to third parties, exit the U.S. market and continue trying to sell Meritage Medical Network.
The company reported second-quarter revenue of $18.5 million with a net loss of $28.7 million, alongside operating expenses totaling $42.2 million.
Informa Markets will manage the massive health technology conference, while HIMSS will continue overseeing content and programming.